Swiss health consulting firm bought by US company

Please login or
register
20.12.2019
handshake

Wellmera, a healthcare consulting firm specializing in market access for the pharmaceutical and biotechnology industries has been acquired by Alira Health, a US-based international healthcare and life sciences advisory firm.

Founded in 2011 in Basel, Wellmera is a dynamic international consulting firm focused on market access, pricing and reimbursement, health economics and real-world evidence. The company helps life sciences companies demonstrate value, optimize patient access, and realize the commercial opportunity for their products throughout the lifecycle.

In early 2018, Wellmera expanded to the US with offices in Cambridge and San Francisco, leveraging synergies for global clients between Europe and the US. The company has now been acquired by the American Alira Health, an international advisory firm that provides a suite of integrated services designed to help healthcare and life science companies innovate and grow across their product and business lifecycles.

Wellmera brings a wealth of experience for the development of Alira Health’s suite of healthcare advisory services. The Swiss-team will also help Alira to advance its mission of enabling healthcare transformation by supporting clients across their product and corporate lifecycles, with services in product development, regulatory, clinical, strategic consulting, and transaction advisory.

"The Wellmera team is excited to join Alira Health," says Jean-François Ricci, President and Principal at Wellmera. "This partnership allows us to bring our market access expertise to a larger global organization, helping us to impact patient care on an even greater scale. We see many synergies with Alira Health's lifecycle approach, and a feel a strong connection in our passion for healthcare, our quality of work, and the culture of our teams."

Jean-François Ricci will become Executive Vice President of Market Access and will lead Alira Health's Market Access practice, covering pharma, biotech, and digital health in Europe and the United States.

(Press release/ran)

0Comments

More news about

Wellmera AG

rss